Log In
BCIQ
Print this Print this
 

Tafoxiparin (DF01)

  Manage Alerts
Collapse Summary General Information
Company Dilafor AB
DescriptionHeparin derivative with no anticoagulation activity
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase II
Standard IndicationUterine contractions
Indication DetailsPrevent protracted labor after induction of labor; Prevent protracted labor after spontaneous onset of labor; Prevent protracted labor during childbirth
Regulatory Designation
PartnerLee's Pharmaceutical Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/24/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today